STADA ARZNEIMITTEL AG
Business Summary
STADA Arzneimittel AG is a Germany-based manufacturer of pharmaceuticals. The Company operates three business segments: Consumer Healthcare, Specialty Pharmaceuticals, and Generics. The Consumer Healthcare segment offers healthcare products for all categories includes cough and cold, derma, vitamins, minerals and gastro, pain and relief, women’s, and men's health through Nizoral, Zoflora, Grippostad, Silomat and Hirudoid brands. The Specialty pharmaceuticals segment delivers biological medicines, including biosimilars, offer treatment options for patients with chronic and disabling conditions including Cancer, osteoporosis, ophthalmic conditions and autoimmune diseases such as rheumatoid arthritis, Psoriasis and Crohn’s disease. The Generics segment is engaged in production and sales of inexpensive medicines that are known as generics. Its generic drugs are prescription products for the healthcare market that are sold under an International Nonproprietary Name (INN) brand.
Country of Incorporation
Germany
Incorporation Date
2004-08-24
Business Sector
Pharmaceuticals & Medical Research
Company Address
Stadastrasse 2-18
Get access to the below data and more business development tools by signing up for the MENA Company Data product.
- Ownership details
- Corporate structure
- Business classification
- Officers & Directors contact details
- Full company contact details
Multiply your reach by contributing your content to LSEG
LSEG contributed content reaches tens of thousands of buy and sell side professionals around the world through an integrated suite of market intelligence and transaction platforms.NEWS ON THIS COMPANY
TOP PICKS
MOST READ
MOST WATCHED
MOST POPULAR
1.
2.
3.
4.
5.
